The global ambulatory blood pressure monitoring devices market revenue was valued at US$ 161.8 million in 2021 and is expected to reach US$ 309.9 million by 2031. The market is expected to grow at a CAGR (Compound Annual Growth Rate) of 6.7% during the forecast period from 2022 to 2031.

Ambulatory Blood Pressure Monitoring (ABPM) devices that monitor ambulatory blood pressure are made to measure blood pressure accurately while minimizing the effects of white coat hypertension. It monitoring measures blood pressure throughout a 24-hour day to ascertain whether hypertension is present. The cuff of this portable blood pressure monitor is fastened around the upper arm of the body and worn like a belt.

Factors Influencing Market Growth

Increasing numbers of people with high blood pressure and cases of white coat hypertension is driving up demand for ambulatory blood pressure monitors.

The rise in the geriatric population and the rise in the number of hypertension cases increases the demand for portable monitoring equipment. Thus, this factor boosts the market.

Technological advancements in ambulatory blood pressure monitoring devices are anticipated to drive the demand of the market.

The presence of numerous important players who offer these devices. Thus, this factor drives market expansion.

The initiatives taken by governments of various nations to raise public awareness propel the market's expansion.

COVID-19 Pandemic Effect on Market Growth

The COVID-19 pandemic had a positive impact on the market. The pandemic raised the need for remote monitoring systems in healthcare facilities like hospitals and nursing homes. Monitoring blood pressure was essential for infected and vulnerable individuals during COVID-19 to detect hypoxia. As a result, the demand for ambulatory blood pressure monitoring devices increased due to the increased use of ambulatory blood pressure for patient monitoring. This demand is also anticipated to continue to expand throughout the forecast period.

Regional Analysis

North America accounted for the largest market share for ambulatory blood pressure monitoring devices and is predicted to retain its dominance during the forecast period due to a rise in product launches and a rise in regulatory approvals.

However, Asia-Pacific is anticipated to see the greatest CAGR due to a surge in the prevalence of hypertension and the existence of cutting-edge healthcare infrastructure.
Leading Competitors
The leading companies in the ambulatory blood pressure monitoring devices market are:
Bosch & Sohn Gmbh & Co. Kg
BPL LTD.
CONTEC MEDICAL SYSTEMS CO. LTD.
GE Healthcare (A Healthcare Division Of GE Company)
Halma plc.
Baxter (Hill Rom Holdings, Inc.)
Omron Corporation
OSI Systems, Inc. (Spacelabs Healthcare, Inc.)
SCHILLER AG
Vaso Corporation
Others
Segmentation Analysis
The global ambulatory blood pressure monitoring devices market segmentation focuses on Product, End User, and Region.
Segmentation Based on Product
Wrist ABPM Devices
Arm ABPM Devices
Segmentation Based on End User
Ambulatory Surgical Centers (ASCs)
Hospitals
Others
Segmentation Based on Region
North America
U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Europe

Asia-Pacific
China
India
Japan, South Korea
ASEAN
Rest of Asia-Pacific

Middle East & Africa (MEA)
Brazil
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America